CSL Ltd Annual Report 2019

Contents 1 Chairman and CEO’s Letter 2 2 2019 Performance 4 Business performance and highlights 4 Financial highlights 5 3 Our Company 6 Our businesses 6 Our locations 7 Our product portfolio 8 Our research and development pipeline 9 4 CSL Strategy 10 How we create value 12 5 Powered by Innovation 14 Collaboration with and funding of medical research 14 Investment in research and development pipeline 14 Focus on selected therapeutic areas – specialisation 15 New products to market 16 Clinical trials in process and new 18 Clinical trial transparency 18 Leveraging advanced analytics and artificial intelligence 19 Innovation across the value chain 19 6 Global Reach and Impact 21 Global reach and focus 21 Donor management 24 Focus on efficiency, standardised manufacturing 24 processes and integrated supply chain Environment health and safety 25 Supply chain management 25 7 A Trusted Health Partner 26 Product quality and safety 26 Value and access 27 Public policy engagement 28 Secure and reliable supply 29 Pandemic and emergency response 29 Relationships with healthcare professionals 29 regulators and patient groups Responsible marketing and promotion 29 Our expanding footprint 30 Risk management 31 Ethical conduct 31 8 Promising Futures 32 Diversity 32 Attraction and retention 33 Training and development 34 Employee engagement 34 Safety and wellbeing 35 9 Working with Our Communities 36 Our approach 36 Support for patient communities 37 Support for biomedical communities 39 Support for local communities 40 10 Governance 42 Governance structure 42 Board composition 42 Board of Directors 43 Board committees 45 Leadership team 46 Ethics and transparency 48 Disclosure 48 Tax transparency 48 11 Financial Performance 49 12 Share Information 136 13 Medical Glossary 138 Annual General Meeting Wednesday, 16 October 2019 at 1 p.m. New city and venue The Westin Sydney, Grand Ballroom 1 Martin Place Sydney NSW 2000 Share Registry Computershare Investor Services Pty Limited Postal Address: GPO Box 2975 Melbourne VIC 3001 Enquiries within Australia: 1800 646 882 Enquiries outside Australia: +61 3 9415 4178 Website: investorcentre.com Find out more CSL.com CSL Calendar 2019 14 August Annual profit and final dividend announcement 10 September Shares traded ex-dividend 11 September Record date for final dividend 11 October Final dividend paid 16 October Annual General Meeting 31 December Half year ends 2020 12 February Half year profit and interimdividend announcement 11 March Shares traded ex-dividend 12 March Record date for interimdividend 9 April Interimdividend paid 30 June Year ends 19 August Annual profit and final dividend announcement 10 September Shares traded ex-dividend 11 September Record date for final dividend 9 October Final dividend paid 14 October Annual General Meeting 31 December Half year ends About this report This year CSL has combined our financial and non-financial performance in one comprehensive report, linking our sustainability and strategic priorities to our business results. Unless otherwise stated, this Report covers CSL’s subsidiaries as listed on page 119. The report is based on results of CSL’s biennial (2017) sustainability materiality assessment. In addition to an independent audit of our consolidated financial accounts, limited assurance on a selection of corporate responsibility (CR) metrics has been provided by Ernst & Young, and an assurance statement, along withmore detailed Group and CR information including our environmental performance, can be found on CSL.com (Our Company > Corporate Responsibility).